These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31453359)

  • 61. A Systematic Literature Review of Health Utility Values in Breast Cancer.
    Kaur MN; Yan J; Klassen AF; David JP; Pieris D; Sharma M; Bordeleau L; Xie F
    Med Decis Making; 2022 Jul; 42(5):704-719. PubMed ID: 35042379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can cost utility evaluations inform decision making about interventions for low back pain?
    Dagenais S; Roffey DM; Wai EK; Haldeman S; Caro J
    Spine J; 2009 Nov; 9(11):944-57. PubMed ID: 19748833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer.
    Zoratti MJ; Zhou T; Chan K; Levine O; Krahn M; Husereau D; Clifford T; Schunemann H; Guyatt G; Xie F
    MDM Policy Pract; 2019; 4(2):2381468319852594. PubMed ID: 31453359
    [No Abstract]   [Full Text] [Related]  

  • 64. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
    Han R; François C; Toumi M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.
    Zanocco K; Kaltman DJ; Wu JX; Fingeret A; Heller KS; Lee JA; Yeh MW; Sosa JA; Sturgeon C
    Ann Surg Oncol; 2018 Apr; 25(4):949-956. PubMed ID: 29417402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
    Heymach J; Krilov L; Alberg A; Baxter N; Chang SM; Corcoran RB; Dale W; DeMichele A; Magid Diefenbach CS; Dreicer R; Epstein AS; Gillison ML; Graham DL; Jones J; Ko AH; Lopez AM; Maki RG; Rodriguez-Galindo C; Schilsky RL; Sznol M; Westin SN; Burstein H
    J Clin Oncol; 2018 Apr; 36(10):1020-1044. PubMed ID: 29380678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.
    Balentine CJ; Vanness DJ; Schneider DF
    Surgery; 2018 Jan; 163(1):88-96. PubMed ID: 29128178
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A systematic review and meta-analysis of utility estimates in melanoma.
    Tran AD; Fogarty G; Nowak AK; Espinoza D; Rowbotham N; Stockler MR; Morton RL
    Br J Dermatol; 2018 Feb; 178(2):384-393. PubMed ID: 29077983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.